including the modified smooth muscle cell (the main cell type in the human plaque); the apolipoprotein Bcontaining plasma lipoproteins, which are the main sources of lipids; the receptors for apolipoproteins on cell surfaces and their role in regulating intracellular metabolism; the stimulation of smooth muscle cell proliferation by growth factors from plasma and cells (platelets, macrophages, and endothelial cells); the functions of lysosomal enzymes; the importance of endothelial injury; the contributions of macrophages to the cell population; the importance of certain lipoproteins in the development and prevention of plaques; and the modulation of plaque morphology by certain types of dietary fat.
He also reported on a series of experiments in rhesus macaques wherein atherosclerosis caused by eating large amounts of cholesterol was made to regress by consumption of foods low in fat and cholesterol or the administration of bile acid sequestrants with or without probucol.
Comparative Pathology
Thomas B. Clarkson (Winston-Salem, North Carolina) described the comparative pathology of nonhuman primate atherosclerosis. Research on various species of nonhuman primates has demonstrated the suitability of certain ones for the study of particular problems. For instance, older cebus monkeys are more susceptible to atherosclerosis than younger ones, and they have large and complicated plaques of the carotid bifurcation. Squirrel monkeys are genetically predisposed to be hypo-and hyperresponsive to dietary cholesterol; they show lesion complications in the abdominal aorta and exacerbation of the atherosclerotic lesions by experimental diabetes mellitus independently of cholesterolemia; some data on squirrel monkeys suggest a relationship between herpes infection and the development of atherosclerosis.
Rhesus macaques are a valuable model since the pathogenesis of their atherosclerosis resembles that of humans. Cynomolgus macaques are probably the most useful of all macaques in atherosclerosis research because their atherosclerotic lesions become complicated, there are male-female differences in lesion extent, coronary artery atherosclerosis is influenced by personality type and social situation, and myocardial infarction occurs with a relatively high frequency (about 1 in 300 animals at
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Experiment with Rhesus Macaques
A regression experiment initiated in 1972 on male rhesus macaques was also discussed by Dr. Clarkson. Atherosclerosis was induced by either 19 months or 38 months on a high fat, high cholesterol diet. During the next 4 years, the monkeys were maintained on diets that kept their cholesterolemia at either 200 mg/dl or 300 mg/dl, and groups of monkeys were killed after 2 or 4 years on these diets. The potentials for regression were similar in the animals whose atherosclerosis was induced for 19 and for 38 months; however, regression was more apparent in the monkeys with cholesterolemia around 200 mg/dl. An interesting observation was the increase in artery diameter associated with the size of the intimal lesions. Furthermore, atherosclerosis regressed in the majority of the hyporesponder (HO) monkeys with cholesterolemia around 300 mg/dl, whereas it progressed in the majority of the hyperresponders (HR) at that level of plasma cholesterol.
Experiment with Cynomolgus Macaques
Dr. Malinow discussed the suitability of cynomolgus macaques for regression studies. Lipoprotein levels were observed in HO and HR monkeys on a chow diet and on semipurified diets high in saturated fat, with or without added cholesterol. The HO monkeys had lower levels of plasma cholesterol than the HR monkeys, even when they ate monkey chow, which is almost free of cholesterol. Eating food rich in saturated fat decreased high density lipoprotein-2 (HDL,) and increased HDLj concentrations in both types of monkeys. The addition of cholesterol to the diet increased very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) more in the HR than in the HO monkeys. Although HDL, increased in the HO monkeys, HDL, and HDLj decreased in the HR monkeys.
Cynomolgus macaques may exhibit minimal or advanced atherosclerosis at similar plasma levels; the former are called hyporeactors ( R -) and the latter hyperreactors (R + ). This phenomenon was first observed in rabbits.
1 Cholesterol-fed cynomolgus macaques show fatty cellular infiltration of the media that correlates positively with the extent of intimal involvement. The medial infiltration decreases during regression, so it is unlikely that an immunologic mechanism is involved.
Cynomolgus macaques constitute an excellent model for the study of regression under the following conditions: 1) atherosclerosis is induced during a 6-month intake of semipurified food containing 1.2 mg of cholesterol/Kcal; 2) animals are allocated to experimental groups by a strictly randomized procedure; 3) there are sufficient numbers of animals in each group. The effects of an alfalfa meal extract, operationally named alfalfa saponins, were discussed. These saponins reduced cholesterolemia and induced regression of aortic and coronary atherosclerosis without signs of toxicity.
Diet-Induced Changes In Lipids
Victor Blaton (Bruges, Belgium) described in detail the plasma lipoprotein lipids of nonhuman primates and the changes induced by different diets. Detailed analyses of lipids and fatty acids of plasma lipoproteins were designed to relate the diet-induced changes in type and composition of plasma lipoproteins to arterial lesions in nonhuman primates. Similar studies on the effects of diets rich in polyunsaturated triglycerides and polyunsaturated phosphatidyl-choline on human and nonhuman plasma lipoproteins were discussed. Finally, changes in the composition of plasma lipoproteins were correlated with the regression of atherosclerosis in rhesus macaques on diets rich in polyunsaturated fatty acids and containing cholestyramine.
SEM and TEM Studies
Giorgio Weber (Siena, Italy) described a scanning electron microscopic and transmission electron microscopic study of the regression of arterial lesions in cholesterol-fed rhesus macaques, cynomolgus macaques, and rabbits. Lesions regressed in monkeys when plasma cholesterol levels decreased due to dietary interventions or eating of cholestyramine. In rabbits, regression was observed after partial ileal bypass, and was associated with a large drop in cholesterolemia. Dr. Weber also described the glycocalyx stained with concanavalin A in the endothelial surfaces of adult rabbit aortas and coronary, carotid, and femoral arteries. No glycocalyx was observed, however, in the intracranial arteries. He indicated that its absence might be related to a lack of lipoprotein lipase activity which would not allow chylomicron remnants to be trapped, making the cerebral vessels of rabbits resistant to atherosclerosis.
No Degradation of Ether Analogues
Olga Stein, Yezechial Stein, and Gideon Halperin (Jerusalem, Israel) found that ether analogues of cholesteryl esters are not degraded in vitro or in vivo. The influx of these ethers into the arterial wall in cholesterol-fed rabbits correlates well with the mass of cholesteryl ester in atherosclerotic intima and media of the aorta. Since these ether analogues are not degraded, their recovery in the aorta of a rabbit undergoing regression of atherosclerosis could be useful in estimating the amount of cholesteryl ester present before the onset of regression. 
Interactions Between Llplds and Macromolecules
Ladislas Robert, Jean Chaudiere, and Bernard Jacotot (Creteil, France) described the interactions between lipids and intercellular matrix macromolecules of the arterial wall, such as elastin, collagens, proteoglycans, and glycoproteins. Elastin isolated from atherosclerotic human aortas is especially rich in cholesterol esters and free fatty acids. These interactions decrease elasticity and increase susceptibility to elastolysis. The calcium ion enhances the interaction of elastin with lipids. In rabbits maintained on a 1% cholesterol diet and then on a cholesterol-free diet containing 5% oil, elastolysis and intimal proliferation appeared to be independent.
Four different triglycerides were tested during this 3-month, postcholesterol regression period: butter, olive oil, sunflower oil, and primrose oil. Only sunflower oil slowed down or stopped the progression of the lesions. The strongest elastolysis was observed with butter and the strongest intimal proliferation with primrose oil, which is rich in y-linolenic acid.
The method used at the Paris-XII University for clinical pharmacologic studies was also discussed. The usefulness of skin biopsies for the determination (by a computerized quantitative histochemical procedure) of elastolysis and LDL deposition in the dermal intercellular matrix was stressed.
Studies of Human Atherosclerosis

Apoproteln B-Contalnlng Llpoproteins
Kenneth W. Walton (Birmingham, England) discussed human atherosclerotic lesions characterized at all stages of their development by the presence of apolipoprotein B-containing lipoproteins, fibrinogen, and fibronectin. He also illustrated the interaction of apolipoprotein B-containing lipoproteins with the fibers and interstitial matrix of the intimal gel, which gives rise to extracellular deposits, and contrasted these findings with the receptor-mediated and scavenger pathways of intracellular lipid deposits.
Role of Plasma Lipoproteins
Gerd Assmann (Munster, West Germany) discussed the role of plasma lipoproteins in the pathogenesis of atherosclerotic lesions. He emphasized the distribution of lipoprotein apoproteins in lipoproteins; the structure-function relationships of apolipoproteins; the surface receptors that control lipoprotein metabolism; the genetic disorders of lipoprotein metabolism and their possible roles in atherogenesis; and the possible early diagnosis of coronary heart disease based on the epidemiologic study of LDL, HDL, and certain apolipoproteins.
Composition of Interstitial Fluid
Elspeth B. Smith (Aberdeen, Scotland) presented her findings on the composition of interstitial fluid in the intima. The observation that the LDL concentration was twice that in plasma suggested that LDL is trapped between the endothelium and internal elastic lamina. The ratio of LDL to other plasma macromolecules in interstitial fluid was greater than in intimal tissue; this finding does not support the hypothesis of specific reversible sequestration of LDL by components of the connective tissue matrix.
In early proliferative (gelatinous) lesions, there was a large volume of interstitial fluid containing a relatively small concentration of LDL -80% to 200% of the concentration in adjacent normal intima. However, in more mature lesions, water appeared to shift out of the interstitial fluid compartment leaving a small amount of interstitial fluid containing large concentrations of LDL. This phenomenon may be a major factor in the deposition of extracellular lipid in fibrous plaques.
By contrast, in fatty streaks containing numerous fat-filled cells, the LDL concentration was small, and in some samples the interstitial fluid was totally depleted of LDL. These observations suggested that the fat-filled cells internalize and degrade LDL faster than it enters the intima.
Comparison of Lesions In Humans and Monkeys
Herbert C. Stary (New Orleans, Louisiana) described the structure of the coronary arteries and aortas in 300 persons who died of accidental causes between full-term birth and 29 years, and in a small sample of older persons. The lesions were compared to those found in the coronary arteries of the following: 1) rhesus macaques fed high-cholesterol foods for 1 to 24 months; 2) rhesus macaques fed high-cholesterol foods for 3 or 24 months, and then fed low cholesterol foods for 0.5 to 24 months; 3) patas monkeys on a high cholesterol diet for 5 or 10 months; and 4) cynomolgus macaques on a high cholesterol diet for 6 months. Because of the thoroughness of the electron microscopic observations, the fact that the arteries were pressure-perfused, and the extensive number of human subjects included in the survey, this data will probably have an important impact on knowledge of human atherosclerosis and the comparative anatomy of nonhuman primates.
Issues In Human Studies
Richard J. Havel (San Francisco, California) described a study being carried out at the Cardiovascular Research Institute of the University of California, San Francisco. Patients with heterozygous familial hypercholesterolemia treated by the combination of bile acid-binding resin and nicotinic acid are evaluated by serial coronary and femoral angiography. A comparison of this data with information on placebotreated controls is designed to establish whether atherosclerosis can be modified by a significant lowering of the plasma LDL level. He commented on several important issues in human studies including
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sample size, patient motivation and program adherence, problems associated with assigning patients at high risk to placebo preparations, acceptance of two angiographic examinations, adherence to diet and medication, and the need for patients to visit the clinic at monthly intervals for 2 years. A high rate of patient compliance requires a highly motivated and well-trained team of health professionals.
Drug Therapy to Lower Lipid Levels
David H. Blankenhom and Stanley P. Azen (Los Angeles, California) described a therapeutic regimen to decrease lipid levels in humans in order to lessen atherosclerosis. The Computer Estimated Atherosclerosis Index permits measurement of the rate of change in atherosclerotic lesions in the femoral artery, when two angiograms are taken. The results in a group of 180 nonsmoking men, aged 40 to 59, who have had coronary bypass operations, randomly allocated to colestipol-niacin therapy or to a placebo, will establish whether a fall in plasma LDL levels and a rise in plasma HDL levels can induce regression of femoral atherosclerosis. Observation of the coronary and carotid arteries will provide information on the rates of change so intervention strategies can be designed. The investigators reported the status of nine studies currently in progress, as well as a cholesterol-lowering study in progress at the University of Southern California. The data gathered thus far on 66 controls and 71 drug-treated patients have shown a significant reduction in the drug-treated group in cholesterol (25%), LDL cholesterol (41%), and triglycerides (15%); there has been an increase in HDL cholesterol (34%) and significant increases in serum uric acid, alkaline phosphatase, and lactic dehydrogenase. Dr. Azen also commented on statistical issues in human studies, including the allocation ratios, the inappropriateness of a crossover design, the variability in human evaluation of stenosis, the possible error in computer estimation of atherosclerosis, and the problems with sample size.
Angiographic Evidence of Regression in Coronary Arteries
B. Greg Brown, Edward L. Bolson, and Howard T. Dodge (Seattle, Washington) reported angiographic evidence of regression of coronary atherosclerosis in humans. The 47 prospectively enrolled patients underwent elective angiography 18 months after an initial, clinically indicated coronary arteriogram. The 642 coronary segments were serially measured with computer assistance. Of the lesions, 12% progressed and 4% regressed, i.e., decreased in percent stenosis by at least 10.2%. The probability of lesion change was affected by the initial lesion severity and, to a lesser extent, by the patient's age and the extent of hyperlipidemia. The average stenosis change in the progression group was 18%; in the regression group it was 14%. Although regression of coronary atherosclerosis was infrequent in this untreated sample, its occurrence provides encouragement that it may be induced by suitable intervention.
Angiographic Evidence of Regression in Femoral Arteries
Anders G. Olsson (Stockholm, Sweden) reported on his ongoing studies on the regression of femoral atherosclerosis in asymptomatic men with hyperlipoproteinemia. The 60 patients -20 each with type HA, IIB, or IV hyperlipoproteinemia -were assigned to a diet-placebo regimen or to drug treatment (diet plus nicotinic acid and fenofibrate). This study will be completed by the end of 1985; Dr. Olsson discussed here eight pilot cases in which femoral angiography was performed four times over a 2-year period. Regression of atherosclerosis was observed in six men and correlated with a drop in plasma LDL cholesterol levels.
Anatomical Evidence of Regression
M. Rene Malinow reported anatomical evidence of regression of atherosclerosis in humans. A survey of several studies suggested that the extent of atherosclerosis was reduced in certain populations during the lean years of World Wars I and II, and that it is reduced during wasting diseases. However, selection bias, as well as other confounding variables, makes interpretation of these findings difficult. Even if present, regression of atherosclerosis could not be separated from arrest of progression. Many, but not all, investigators agree that patients with cancer show less extensive atherosclerosis than patients without cancer. A large series of cancer and noncancer patients was analyzed, 2 and the findings were consistent with the hypothesis that processes occurring during the terminal stages of cancer are associated with the arrest of progression and with the regression of atherosclerosis. However, because of the uncertainty of retrospective postmortem data, these conclusions are tentative.
